- Product Details
Keywords
- erlotinib hcl
- Erlotinib hydrochloride
- cas 183319-69-9
Quick Details
- ProName: Medicine Grade CAS 183319-69-9 Erlotin...
- CasNo: 183319-69-9
- Molecular Formula: C22H24ClN3O4
- Appearance: white powder
- Application: anti-cancer
- DeliveryTime: immediately
- PackAge: aluminum foil bag
- Port: HK, Shanghai, Shenzhen
- ProductionCapacity: 10 Kilogram/Month
- Purity: 99%
- Storage: cool and dry place
- Transportation: email: wonda-chem@outlook.com
- LimitNum: 10 Gram
Superiority
1.high quality:
quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.
2.reasonable price:
we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.
3.low moq:
no worry about the low moq, our moq is 1 gram or even lower.
4.good service.
fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.
5. fast shipping and secure courier.
we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.
Details
Product Name |
erlotinib hcl |
CAS NO. |
183319-69-9 |
EINECS NO. |
C22H24ClN3O4 |
Molecular formula |
429.8967 |
Molecular weight |
548.2°C at 760 mmHg |
Other Name |
ERLOTINIB HCL SALT; Erlotinib, Hydrochloride Salt; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4- Hydrochloride; quinazolinamine, Hydrochloride Salt |
Erlotinib Hydrochloride is a small molecule inhibitor of the EGFR/HER-1 (human epidermal growth factor receptor) tyrosine kinase. Overexpression of the EGFR is present in many carcinomas, and inhibition of the activating kinase by Erlotinib provides a chemical intervention upon these systems. The inhibition of this tyrosine kinase effectively blocks EGFR activity but does not suppress tumor growth. When combined with 3,3'-diindolylmethane (sc-204624), efficacy against tumor proliferation was demonstrated.
1. Erlotinib hydrochloride is a kind of small molecule epidermal growth factor receptor tyrosine kinase reversible inhibitor. It is mainly used for the second-line or third-line treatment of locally advanced or metastatic non-small cell lung cancer and for the treatment of pancreatic cancer.
2. HER-1/EGFR tyrosine kinase inhibitors.